GSK pro­motes rou­tine im­mu­niza­tions for adults amid post-pan­dem­ic vac­cine back­slide

GSK launched a new ini­tia­tive on Thurs­day and com­mit­ted up to $1 mil­lion in grant fund­ing to im­prove adult rou­tine vac­ci­na­tion rates.

While the pan­dem­ic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.